Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1983 1
1985 1
1986 1
1990 2
1993 2
1995 1
1996 2
1998 4
1999 3
2000 7
2001 4
2002 11
2003 11
2004 10
2005 15
2006 12
2007 20
2008 20
2009 30
2010 21
2011 28
2012 33
2013 38
2014 44
2015 38
2016 54
2017 47
2018 43
2019 47
2020 57
2021 58
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

600 results
Results by year
Filters applied: . Clear all
Page 1
Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.
Fazio C, Biolchi A, Neri A, Tomei S, Vacca P, Ambrosio L, Palmieri A, Mori E, La Gaetana R, Pizza M, Giuliani MM, Serino L, Stefanelli P. Fazio C, et al. Hum Vaccin Immunother. 2021 Jul 3;17(7):2225-2231. doi: 10.1080/21645515.2020.1855951. Epub 2021 Jan 31. Hum Vaccin Immunother. 2021. PMID: 33522380 Free PMC article.
The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invasive meningococcal disease (IMD) and may potentially offer protection against strains belonging to non-B serogroups.This study aimed t …
The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invas …
Product review on the IMD serogroup B vaccine Bexsero®.
Deghmane AE, Taha MK. Deghmane AE, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2020043. doi: 10.1080/21645515.2021.2020043. Epub 2022 Feb 22. Hum Vaccin Immunother. 2022. PMID: 35192786 Free PMC article.
Bexsero is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates. ...Although the vaccine does not seem to …
Bexsero is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This va …
Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress.
Elkamhawy A, Woo J, Gouda NA, Kim J, Nada H, Roh EJ, Park KD, Cho J, Lee K. Elkamhawy A, et al. Antioxidants (Basel). 2021 Oct 12;10(10):1604. doi: 10.3390/antiox10101604. Antioxidants (Basel). 2021. PMID: 34679739 Free PMC article.
Monoamine oxidase B (MAO-B) metabolizes dopamine and plays an important role in oxidative stress by altering the redox state of neuronal and glial cells. MAO-B inhibitors are a promising therapeutical approach for Parkinson's disease (PD). ...
Monoamine oxidase B (MAO-B) metabolizes dopamine and plays an important role in oxidative stress by altering the redox state o …
Circular dichroism and resonance Raman spectroscopies of bacteriochlorophyll b-containing LH1-RC complexes.
Kimura Y, Yamashita T, Seto R, Imanishi M, Honda M, Nakagawa S, Saga Y, Takenaka S, Yu LJ, Madigan MT, Wang-Otomo ZY. Kimura Y, et al. Photosynth Res. 2021 May;148(1-2):77-86. doi: 10.1007/s11120-021-00831-5. Epub 2021 Apr 8. Photosynth Res. 2021. PMID: 33834357
This may reflect differences in the conjugation system of the bacteriochlorin between BChl b and BChl a and/or the differences in the pigment organization between the BChl b- and BChl a-containing LH1 complexes. ...A linear correlation was found between the redshift …
This may reflect differences in the conjugation system of the bacteriochlorin between BChl b and BChl a and/or the differences in the …
Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine.
Fagnocchi L, Biolchi A, Ferlicca F, Boccadifuoco G, Brunelli B, Brier S, Norais N, Chiarot E, Bensi G, Kroll JS, Pizza M, Donnelly J, Giuliani MM, Delany I. Fagnocchi L, et al. Infect Immun. 2013 Feb;81(2):560-9. doi: 10.1128/IAI.01085-12. Epub 2012 Dec 10. Infect Immun. 2013. PMID: 23230289 Free PMC article.
The NadA adhesin is a major component of 4CMenB, a novel vaccine to prevent meningococcus serogroup B (MenB) infection. ...Our results suggest that during infectious disease, NadR repression is alleviated due to niche-specific signals, resulting in high levels of …
The NadA adhesin is a major component of 4CMenB, a novel vaccine to prevent meningococcus serogroup B (MenB) infection. ...Our …
The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.
Masignani V, Pizza M, Moxon ER. Masignani V, et al. Front Immunol. 2019 Apr 16;10:751. doi: 10.3389/fimmu.2019.00751. eCollection 2019. Front Immunol. 2019. PMID: 31040844 Free PMC article. Review.
The complete genome sequence of an isolate of Neisseria meningitidis serogroup B (MenB) was systematically analyzed to identify proteins predicted to be secreted or exported to the outer membrane. ...The resulting multivalent vaccine formulation selected consisted of three …
The complete genome sequence of an isolate of Neisseria meningitidis serogroup B (MenB) was systematically analyzed to identify prote …
Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.
Green LR, Lucidarme J, Dave N, Chan H, Clark S, Borrow R, Bayliss CD. Green LR, et al. J Clin Microbiol. 2018 Aug 27;56(9):e00204-18. doi: 10.1128/JCM.00204-18. Print 2018 Sep. J Clin Microbiol. 2018. PMID: 29950334 Free PMC article.
A recombinant NadA protein is one of the four major protective antigens of 4C-MenB (Bexsero), a vaccine developed for serogroup B Neisseria meningitidis (MenB). ...Low-expression repeat numbers were present in 83% of 179 MenB isolates with NadA-2/3 or NadA
A recombinant NadA protein is one of the four major protective antigens of 4C-MenB (Bexsero), a vaccine developed for serogroup B
Epitope and Paratope Mapping by HDX-MS Combined with SPR Elucidates the Difference in Bactericidal Activity of Two Anti-NadA Monoclonal Antibodies.
Grauslund LR, Calvaresi V, Pansegrau W, Norais N, Rand KD. Grauslund LR, et al. J Am Soc Mass Spectrom. 2021 Jul 7;32(7):1575-1582. doi: 10.1021/jasms.0c00431. Epub 2021 Mar 8. J Am Soc Mass Spectrom. 2021. PMID: 33683906 Free article.
Bexsero is a multicomponent vaccine against Neisseria meningitidis serogroup B in which one of the key vaccine antigens is Neisserial adhesin A (NadA), a trimeric coiled-coil protein. ...In addition, we use surface plasmon resonance (SPR) to investigate the stoichio …
Bexsero is a multicomponent vaccine against Neisseria meningitidis serogroup B in which one of the key vaccine antigens is Neisserial …
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Bouffet E, Larouche V, Campbell BB, Merico D, de Borja R, Aronson M, Durno C, Krueger J, Cabric V, Ramaswamy V, Zhukova N, Mason G, Farah R, Afzal S, Yalon M, Rechavi G, Magimairajan V, Walsh MF, Constantini S, Dvir R, Elhasid R, Reddy A, Osborn M, Sullivan M, Hansford J, Dodgshun A, Klauber-Demore N, Peterson L, Patel S, Lindhorst S, Atkinson J, Cohen Z, Laframboise R, Dirks P, Taylor M, Malkin D, Albrecht S, Dudley RW, Jabado N, Hawkins CE, Shlien A, Tabori U. Bouffet E, et al. J Clin Oncol. 2016 Jul 1;34(19):2206-11. doi: 10.1200/JCO.2016.66.6552. Epub 2016 Mar 21. J Clin Oncol. 2016. PMID: 27001570
[Molecular characteristics of serogroup B neisseria meningitidis, China].
Zhu BQ, Gao WY, Xu L, Gao Y, Shao ZJ. Zhu BQ, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):153-158. doi: 10.3760/cma.j.issn.0253-9624.2019.02.006. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 30744288 Chinese.
Objective: To investigate the molecular characteristics of serogroup B neisseria meningitidis in China. Methods: Total of 485 (100 strains isolated from cerebrospinal fluid or blood samples of encephalomyelitis cases, and 385 strains isolated from nasopharynx of healthy ca …
Objective: To investigate the molecular characteristics of serogroup B neisseria meningitidis in China. Methods: Total of 485 (100 st …
600 results